XSpray Pharma är noterat på First North men meddelade i slutet av oktober 2018 att de inom 12 månader ska flytta sin notering till Nasdaq Stockholms huvudlista. Uppdatering: I början av december 2018 gjorde XSpray en riktad emission på 92 Mkr, och i samband med det upprepade man sin plan att byta till Nasdaq Stockholm, och tidsplanen man angav var 2019.
Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) today announces that Xspray has signed a term sheet with Pharmacare Premium Ltd. for a new manufacturing facility in Malta based on its patented technology platform. The new production lines will be placed …
Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. XSpray Pharma är noterat på First North men meddelade i slutet av oktober 2018 att de inom 12 månader ska flytta sin notering till Nasdaq Stockholms huvudlista. Uppdatering: I början av december 2018 gjorde XSpray en riktad emission på 92 Mkr, och i samband med det upprepade man sin plan att byta till Nasdaq Stockholm, och tidsplanen man angav var 2019. Xspray Pharma AB (publ) (556649-3671).
Company News. Karolinska Development, Xspray dealKarolinska divested its stake in XSpray Microparticles to a consortium led by The Foundation for Baltic..kinase inhibitor which is being developed with XSpray ’s HyNap drug formulation technology to treat Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Kallelse till årsstämma i Xspray Pharma AB (publ) tis, apr 14, 2020 17:30 CET. Aktieägarna i Xspray Pharma AB (publ), org.nr 556649-3671, kallas till årsstämma torsdagen den 14 maj 2020 klockan 11.00 i Advokatfirman Vinges lokaler, Stureplan 8, Stockholm. Senaste nyheter om - Xspray Pharma, aktieanalys, kursutveckling och rapporter. Xspray Pharma komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här.
About Xspray Pharma Xspray Pharma AB (publ) is a product development company with multiple product candidates in clinical development. Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer.
XSPRAY PHARMA AB (PUBL) : News, information and stories for XSPRAY PHARMA AB (PUBL) | Nasdaq Stockholm: XSPRAY | Nasdaq Stockholm Xspray Pharma publishes its annual report for 2020 Press release 2021-03-18 Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 Press release 2021-03-05 Xspray Pharma publishes its annual report for 2020 Press release 2021-03-18 Xspray Pharma aims to submit its improved version of dasatinib for market approval application in second half of 2021 Press release 2021-03-05 View the latest XSpray Pharma AB (XSPRAY) stock price, news, historical charts, analyst ratings and financial information from WSJ. XSPRAY PHARMA AB (PUBL) : Financial news and information Stock XSPRAY PHARMA AB (PUBL) | NASDAQ STOCKHOLM AB: XSPRAY | NASDAQ STOCKHOLM AB Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. About Xspray Pharma Xspray Pharma AB (publ) is a product development company with multiple product candidates in clinical development. Xspray uses its innovative, patented RightSize technology to develop improved and generic versions of marketed drugs, primarily protein kinase inhibitors (PKIs) for the treatment of cancer.
View the latest XSpray Pharma AB (XSPRAY) stock price, news, historical charts, analyst ratings and financial information from WSJ.
1.12%.
Directed share issue in Impact Coatings. 2021.03.11. Impact Coatings AB has carried out a directed share issue of approximately 120 MSEK to a number
Tillgång till Affärsvärldens unika verktyg: Analysarkivet, Uppföljning, Pref-guiden och Uppsidan. Kontakt. Affärsvärlden Börsplus AB pren@affarsvarlden.se 079-10
XSpray Pharma AB (publ).
Tolka ekg lathund
Xsprays unika teknologi gör det möjligt att förädla läkemedel som inte bara ger ett bättre liv för patienter, utan till och med kan rädda Xspray Pharma meddelar resultat från två bioekvivalensstudier med justerad tablettformulering av HyNap-Dasa (ANDA). Regulatoriskt pressmeddelande Aktieägarna i Xspray Pharma AB (publ), org.nr 556649-3671, kallas till årsstämma torsdagen den 14 maj 2020 klockan 11.00 i Advokatfirman Vinges lokaler, This company has moved to a main market, therfore we do not show updates relating to this company. News; Instruments 15 sep. 2020 — Xspray Pharma AB (publ) engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden.
Nachrichten zur Aktie XSpray Pharma AB Registered Shs | A2H48J | SE0009973563.
Administrativa uppgifter engelska
News. Directed share issue in Impact Coatings. 2021.03.11. Impact Coatings AB has carried out a directed share issue of approximately 120 MSEK to a number
Pharma AB Xspray pharma forum, Asarina pharma forum, Synact pharma 21 sep.
XSPRAY PHARMA AB (PUBL) : Press releases relating to XSPRAY PHARMA AB Most Read News. Hot News. Top Fundamentals. Top Capitalization. Top Yield. Top PER. Top
2021-03-16 Xspray Pharma AB Read More. BioCentury | Oct 6, 2017. Finance. Nov 2, 2015. Company News. Karolinska Development, Xspray dealKarolinska divested its stake in XSpray Microparticles to a consortium led by The Foundation for Baltic..kinase inhibitor which is being developed with XSpray ’s HyNap drug formulation technology to treat Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.
Affärsvärlden Börsplus AB pren@affarsvarlden.se 079-10 XSpray Pharma AB (publ). kr 110.00+0.92%. BioInvent International AB. kr 46.92-0.17%. Cantargia AB. kr 29.60-0.50%.